1136P Cosibelimab in advanced cutaneous squamous cell carcinoma (CSCC): Longer-term efficacy and safety results from pivotal study.

Autor: Muñoz-Couselo, E.1 (AUTHOR), Montaudie, H.2 (AUTHOR), Berciano Guerrero, M.A.3 (AUTHOR), Alamo De La Gala, M.D.C.4 (AUTHOR), Charles, J.5 (AUTHOR), Quereux, G.6 (AUTHOR), Nardin, C.7 (AUTHOR), Tur, R. Yaya8 (AUTHOR), Dalle, S.9 (AUTHOR), Beylot-Barry, M.10 (AUTHOR), Ladwa, R.11 (AUTHOR), McGrath, M.12 (AUTHOR), Brungs, D.13 (AUTHOR), Harris, D.14 (AUTHOR), Shue, H.15 (AUTHOR), Tazbirkova, A.16 (AUTHOR), Fourie, S.J.17 (AUTHOR), Malan, D.R.18 (AUTHOR), Oliviero, J.19 (AUTHOR), Clingan, P.13 (AUTHOR)
Zdroj: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS745-S746. 2p.
Databáze: Academic Search Ultimate